Vietnam Companion Animal Osteoarthritis to Reach $23.8M
Vietnam Companion Animal Osteoarthritis to Reach $23 .8M The Vietnam companion animal osteoarthritis market covers recurring treatment and care for diagnosed mobility impairment in pets, including prescription pharmaceuticals, joint nutraceuticals, advanced analgesics and biologics, selected adjunct therapies, and OA-focused rehabilitation. Ken Research estimates the market at USD 12.4 million in 2025 , with value projected to reach USD 23.8 million by 2031 at an 11.5% forecast CAGR. The Vietnam Companion Animal Osteoarthritis Market therefore represents a small but rapidly formalizing chronic-care category rather than a simple pet-population story. The growth mechanism is conversion: more symptomatic dogs and cats must move from owner observation into diagnosis, veterinarian-supervised treatment, refills, monitoring, and rehabilitation. Premium injectables and biologics can raise revenue per treated animal, but affordability, provincial access, regulatory registration, and foll...